Review of use of inactivated poliovirus vaccine in campaigns to control type 2 circulating vaccine derived poliovirus (cVDPV) outbreaks
出版年份 2022 全文链接
标题
Review of use of inactivated poliovirus vaccine in campaigns to control type 2 circulating vaccine derived poliovirus (cVDPV) outbreaks
作者
关键词
Outbreak response, Campaigns, Circulating vaccine-derived poliovirus, Inactivated poliovirus vaccine, Oral poliovirus vaccine
出版物
VACCINE
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2022-03-29
DOI
10.1016/j.vaccine.2022.03.027
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Needle-free injectors for mass administration of fractional dose inactivated poliovirus vaccine in Karachi, Pakistan: A survey of caregiver and vaccinator acceptability
- (2020) Catherine Daly et al. VACCINE
- Evolving epidemiology of poliovirus serotype 2 following withdrawal of the type 2 oral poliovirus vaccine
- (2020) G. R. Macklin et al. SCIENCE
- Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, July 2019–February 2020
- (2020) Mary M. Alleman et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trial
- (2020) Ananda S Bandyopadhyay et al. LANCET INFECTIOUS DISEASES
- Immunogenicity of full and fractional dose of inactivated poliovirus vaccine for use in routine immunisation and outbreak response: an open-label, randomised controlled trial
- (2019) Cynthia J Snider et al. LANCET
- Vaccine schedules and the effect on humoral and intestinal immunity against poliovirus: a systematic review and network meta-analysis
- (2019) Grace R Macklin et al. LANCET INFECTIOUS DISEASES
- Immunogenicity of type 2 monovalent oral and inactivated poliovirus vaccines for type 2 poliovirus outbreak response: an open-label, randomised controlled trial
- (2018) Khalequ Zaman et al. LANCET INFECTIOUS DISEASES
- Modeling Poliovirus Transmission in Pakistan and Afghanistan to Inform Vaccination Strategies in Undervaccinated Subpopulations
- (2018) Radboud J. Duintjer Tebbens et al. RISK ANALYSIS
- Evaluation of vaccine derived poliovirus type 2 outbreak response options: A randomized controlled trial, Karachi, Pakistan
- (2018) Ali Faisal Saleem et al. VACCINE
- Strategic Response to an Outbreak of Circulating Vaccine-Derived Poliovirus Type 2 — Syria, 2017–2018
- (2018) Chukwuma Mbaeyi et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Immunogenicity of Different Routine Poliovirus Vaccination Schedules: A Randomized, Controlled Trial in Karachi, Pakistan
- (2017) Ali F Saleem et al. JOURNAL OF INFECTIOUS DISEASES
- Inactivated polio vaccines from three different manufacturers have equivalent safety and immunogenicity when given as 1 or 2 additional doses after bivalent OPV: Results from a randomized controlled trial in Latin America
- (2017) Eduardo Lopez-Medina et al. VACCINE
- Needle adapters for intradermal administration of fractional dose of inactivated poliovirus vaccine: Evaluation of immunogenicity and programmatic feasibility in Pakistan
- (2017) Ali Faisal Saleem et al. VACCINE
- Fractional-Dose Inactivated Poliovirus Vaccine Campaign — Sindh Province, Pakistan, 2016
- (2017) Aslam Pervaiz et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Characterization of outbreak response strategies and potential vaccine stockpile needs for the polio endgame
- (2016) Radboud J. Duintjer Tebbens et al. BMC INFECTIOUS DISEASES
- Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial
- (2016) Edwin J Asturias et al. LANCET
- Immunogenicity and safety of a novel monovalent high-dose inactivated poliovirus type 2 vaccine in infants: a comparative, observer-blind, randomised, controlled trial
- (2016) Xavier Sáez-Llorens et al. LANCET INFECTIOUS DISEASES
- Safety and immunogenicity of inactivated poliovirus vaccine when given with measles–rubella combined vaccine and yellow fever vaccine and when given via different administration routes: a phase 4, randomised, non-inferiority trial in The Gambia
- (2016) Ed Clarke et al. Lancet Global Health
- Fractional-Dose Inactivated Poliovirus Vaccine Immunization Campaign — Telangana State, India, June 2016
- (2016) Sunil Bahl et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Immunogenicity of a new routine vaccination schedule for global poliomyelitis prevention: an open-label, randomised controlled trial
- (2015) Roland W Sutter et al. LANCET
- Immunogenicity of three doses of bivalent, trivalent, or type 1 monovalent oral poliovirus vaccines with a 2 week interval between doses in Bangladesh: an open-label, non-inferiority, randomised, controlled trial
- (2015) Concepción F Estívariz et al. LANCET INFECTIOUS DISEASES
- Immunogenicity of poliovirus vaccines in chronically malnourished infants: A randomized controlled trial in Pakistan
- (2015) Ali Faisal Saleem et al. VACCINE
- Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trial
- (2015) Abhijeet Anand et al. VACCINE
- Immune responses after fractional doses of inactivated poliovirus vaccine using newly developed intradermal jet injectors: A randomized controlled trial in Cuba
- (2015) Sonia Resik et al. VACCINE
- Molecular epidemiology of silent introduction and sustained transmission of wild poliovirus type 1, Israel, 2013
- (2014) L M Shulman et al. Eurosurveillance
- Progress Toward Global Interruption of Wild Poliovirus Transmission, 2010-2013, and Tackling the Challenges to Complete Eradication
- (2014) S. G. F. Wassilak et al. JOURNAL OF INFECTIOUS DISEASES
- Immunogenicity and Effectiveness of Routine Immunization With 1 or 2 Doses of Inactivated Poliovirus Vaccine: Systematic Review and Meta-analysis
- (2014) Nicholas C. Grassly JOURNAL OF INFECTIOUS DISEASES
- Vaccine-Derived Polioviruses
- (2014) C. C. Burns et al. JOURNAL OF INFECTIOUS DISEASES
- Vaccine-Associated Paralytic Poliomyelitis: A Review of the Epidemiology and Estimation of the Global Burden
- (2014) L. R. Platt et al. JOURNAL OF INFECTIOUS DISEASES
- Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: an open-label, randomised controlled trial
- (2014) Jacob John et al. LANCET
- Efficacy of inactivated poliovirus vaccine in India
- (2014) H. Jafari et al. SCIENCE
- Priming after a Fractional Dose of Inactivated Poliovirus Vaccine
- (2013) Sonia Resik et al. NEW ENGLAND JOURNAL OF MEDICINE
- Poliovirus vaccination options for achieving eradication and securing the endgame
- (2013) Concepción F Estívariz et al. Current Opinion in Virology
- Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6–9 months in Moradabad, India: a community-based, randomised controlled trial
- (2011) Concepción F Estívariz et al. LANCET INFECTIOUS DISEASES
- Monovalent type 1 oral poliovirus vaccine among infants in India: Report of two randomized double-blind controlled clinical trials
- (2011) T. Jacob John et al. VACCINE
- Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial
- (2010) Roland W Sutter et al. LANCET
- Monovalent Type 1 Oral Poliovirus Vaccine in Newborns
- (2008) Nasr El-Sayed et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now